CalciMedica is trading at $1.30, up 5.69% in after-hours trading; no clear company-specific catalyst was identified.
- Available coverage likewise described the October 23 rally as lacking a clear catalyst.
- The CFO resignation and $25 million at-the-market stock program were reported earlier, not as new October 23 announcements.
- Shares also rose 6.96% during the October 23 regular session, according to the supplied price context.